In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

So, while a number of ASO therapies have been ... and could potentially lead to organoid-based therapy for other digestive tract conditions, such as Crohn’s disease. “We are now on the cusp ...

Children's Mercy Kansas City has achieved a significant advancement toward the treatment of rare genetic diseases through the ...

The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. To date, n-Lorem received over 300 applications for treatment with more ...

The Massachusetts based biotech will now press ahead with human trials for its antisense oligonucleotide (ASO) therapy, ...

believes he has found a promising custom genetic treatment: antisense oligonucleotides that deplete the disease-causing gene ...

However, former Prime Minister Taro Aso suggested otherwise in his remarks that could be considered outright sexist and extremely inappropriate. When it comes to making unsuitable comments ...

Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of ALS ...

The methods and protocols generated in this study are accessible and can be implemented in any standard research laboratory without the need for ...

The FDA is putting Atara’s active Investigational New Drug applications on hold due to manufacturing concerns at a ...